中国现代药物应用
中國現代藥物應用
중국현대약물응용
CHINESE JOURNAL OF MODERN DRUG APPLICATION
2015年
14期
6-7
,共2页
N末端脑钠肽%不典型%川崎病%早期诊断
N末耑腦鈉肽%不典型%川崎病%早期診斷
N말단뇌납태%불전형%천기병%조기진단
N-terminal pro-brain natriuretic peptide%Atypical%Kawasaki disease%Early diagnosis
目的:探讨N末端脑钠肽在不典型的川崎病早期诊断中的作用。方法回顾性分析10例川崎病小儿的临床资料,其中症状不典型的川崎病6例(症状不典型组)、症状典型的川崎病4例(症状典型组),同时选取发热5 d以上小儿6例作为对照组。入院时取静脉血,按规定检测N末端脑钠肽,并作心脏彩色B超检查。治疗10 d后进行复测。结果症状不典型组和症状典型组患儿的N末端脑钠肽检测值均呈不同程度的升高;对照组小儿N末端脑钠肽检测值未见升高。川崎病组明显高于对照组,差异具有统计学意义(P<0.01)。治疗10 d后进行复测,川崎病组的N末端脑钠肽检测值均呈现不同程度的下降或降至正常,与治疗前比较,差异均具有统计学意义(P<0.05)。结论检测N末端脑钠肽有助于早期诊断症状不典型的川崎病,并有助于评估病情和指导治疗,协助早期防治冠状动脉病变,值得临床推广应用。
目的:探討N末耑腦鈉肽在不典型的川崎病早期診斷中的作用。方法迴顧性分析10例川崎病小兒的臨床資料,其中癥狀不典型的川崎病6例(癥狀不典型組)、癥狀典型的川崎病4例(癥狀典型組),同時選取髮熱5 d以上小兒6例作為對照組。入院時取靜脈血,按規定檢測N末耑腦鈉肽,併作心髒綵色B超檢查。治療10 d後進行複測。結果癥狀不典型組和癥狀典型組患兒的N末耑腦鈉肽檢測值均呈不同程度的升高;對照組小兒N末耑腦鈉肽檢測值未見升高。川崎病組明顯高于對照組,差異具有統計學意義(P<0.01)。治療10 d後進行複測,川崎病組的N末耑腦鈉肽檢測值均呈現不同程度的下降或降至正常,與治療前比較,差異均具有統計學意義(P<0.05)。結論檢測N末耑腦鈉肽有助于早期診斷癥狀不典型的川崎病,併有助于評估病情和指導治療,協助早期防治冠狀動脈病變,值得臨床推廣應用。
목적:탐토N말단뇌납태재불전형적천기병조기진단중적작용。방법회고성분석10례천기병소인적림상자료,기중증상불전형적천기병6례(증상불전형조)、증상전형적천기병4례(증상전형조),동시선취발열5 d이상소인6례작위대조조。입원시취정맥혈,안규정검측N말단뇌납태,병작심장채색B초검사。치료10 d후진행복측。결과증상불전형조화증상전형조환인적N말단뇌납태검측치균정불동정도적승고;대조조소인N말단뇌납태검측치미견승고。천기병조명현고우대조조,차이구유통계학의의(P<0.01)。치료10 d후진행복측,천기병조적N말단뇌납태검측치균정현불동정도적하강혹강지정상,여치료전비교,차이균구유통계학의의(P<0.05)。결론검측N말단뇌납태유조우조기진단증상불전형적천기병,병유조우평고병정화지도치료,협조조기방치관상동맥병변,치득림상추엄응용。
Objective To investigate effect of N-terminal pro-brain natriuretic peptide in early diagnosis of atypical Kawasaki disease. Methods Clinical data of 10 children with Kawasaki disease were retrospectively analyzed. There were 6 cases with atypical Kawasaki disease (atypical symptom group) and 4 cases with typical Kawasaki disease (typical symptom group). Another 6 children with fever for over 5 d were taken as control group. N-terminal pro-brain natriuretic peptide was detected in venous blood taken during their admission. They received heart color B ultrasound. Reexamination was made after 10 d of treatment. Results N-terminal pro-brain natriuretic peptide had different levels of increase in both atypical symptom group and typical symptom group, while the control group had no increased value. Kawasaki disease groups had much higher value than the control group, and their difference had statistical significance (P<0.01). Reexamination after 10 d of treatment showed that N-terminal pro-brain natriuretic peptide had different levels of decrease in Kawasaki disease groups. Compared with those before treatment, their differences all had statistical significance (P<0.05). Conclusion Detection of N-terminal pro-brain natriuretic peptide is helpful for early diagnosis of atypical Kawasaki disease. This method is also helpful to evaluating disease and guiding treatment, as well as early preventing coronary artery disease. It is worthy of clinical promotion and application.